Sotorasib Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 960 mg
Reference Brands: Lumakras (USA/EU)
Category: Oncology Cancer Care
Sotorasib (Lumakras) is used to treat adults with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) who have received at least one prior systemic therapy. It works by selectively inhibiting the KRAS G12C protein, preventing cancer cell growth and proliferation, and thereby slowing disease progression. Sotorasib is available in Tablets and strengths such as 960 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Sotorasib is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Sotorasib can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Sotorasib is used to treat non-small cell lung cancer (NSCLC) with KRAS G12C mutations in patients who have received prior therapies.
Sotorasib is a small-molecule inhibitor that selectively targets the KRAS G12C mutant protein, blocking cancer cell growth.
The trade name is Lumakras.
Lumakras is manufactured by Amgen.
The generic name is sotorasib.
The brand name is Lumakras.
It is manufactured in the United States by Amgen.
Related Products
Momelotinib
Strength:
100 mg, 150 mg, 200 mg
Form: Tablets
Reference Brands: Ojjaara (USA)
View Details
Nirogacestat
Strength:
50 mg
Form: Tablets
Reference Brands: Generic formulations marketed under different names
View Details
Nintedanib
Strength:
100 mg, 150 mg
Form: Capsules
Reference Brands: Ofev (USA, EU), Vargatef (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
